ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Proprietary Extract Of Houttuynia Cordata

Also known as: Houttuynia, fish mint, chameleon plant, dokudami, yuxingcao, Houttuynia cordata

Overview

*Houttuynia cordata* Thunb. is a perennial herb native to East Asia, traditionally used in medicine and as a vegetable. It is cultivated in countries like China, Japan, Korea, and Southeast Asia. Historically, it has been valued for its purported anti-inflammatory, antibacterial, and antiviral properties. Modern research explores its potential in conditions such as rhinosinusitis and inflammatory bowel disease (IBD). The plant is rich in bioactive compounds including volatile oils, polysaccharides, and flavonoids. However, its use is complicated by the potential presence of aristolochic acid alkaloids, which are known to be nephrotoxic and potentially carcinogenic. The current research maturity level is early to intermediate, with most clinical studies being preliminary and lacking robust, high-quality evidence to definitively support its efficacy and safety.

Benefits

While *Houttuynia cordata* has a history of traditional use and promising preclinical data, robust clinical evidence for its benefits in humans is largely lacking. A systematic review protocol is underway to assess its efficacy for nasal irrigation in rhinosinusitis, but full results with quantified outcomes, confidence intervals, or statistical significance are not yet published [1, 2]. Therefore, no high-quality randomized controlled trials (RCTs) with adequate sample sizes (n≥30 per group) and clear effect sizes are currently available to substantiate clinical benefits. Preclinical and in vitro studies suggest anti-inflammatory, antibacterial, and antiviral activities, but these findings have not been confirmed in human clinical trials [3]. Consequently, there is no established evidence for population-specific benefits, effect sizes, clinical significance, or time course of benefits.

How it works

The proposed mechanisms of action for *Houttuynia cordata* primarily involve its bioactive compounds, such as volatile oils, polysaccharides, and flavonoids. These compounds are thought to modulate inflammatory cytokines, exert antioxidant effects, and possess direct antimicrobial properties. In preclinical models of inflammatory bowel disease (IBD), *Houttuynia cordata* may regulate the intestinal microenvironment. At a molecular level, its effects are believed to involve signaling pathways like NF-κB and MAPK, based on in vitro and animal studies. The plant's interaction with body systems has been primarily studied in the context of mucosal immunity, particularly in nasal and intestinal tissues. However, human pharmacokinetic data regarding the absorption and bioavailability of its key constituents are unavailable, and their bioavailability is presumed to be low due to rapid metabolism.

Side effects

The overall safety of *Houttuynia cordata* in humans is poorly established due to limited clinical data. A significant safety concern arises from the potential presence of aristolochic acid alkaloids, which are known to be nephrotoxic (damaging to the kidneys) and potentially carcinogenic (cancer-causing) [3]. While common or uncommon side effects have not been reported in clinical studies due to a lack of data, the risk of rare but severe nephrotoxicity and carcinogenicity from aristolochic acid analogs is a critical consideration. There is no available data on drug interactions. *Houttuynia cordata* is contraindicated in individuals with existing kidney disease or those at risk for aristolochic acid toxicity. Furthermore, it is not recommended for use during pregnancy, lactation, or in children due to these significant safety concerns and the absence of adequate safety data for these vulnerable populations.

Dosage

The minimum effective dose, optimal dosage ranges, and maximum safe dose for *Houttuynia cordata* are not established due to a lack of rigorous clinical research. Traditional preparations vary widely, and there is no evidence-based guidance for specific dosages or timing considerations. While nasal irrigation preparations have been studied, the optimal formulation and concentration remain unclear [1, 2]. There are no human data available regarding absorption factors or any required cofactors for its efficacy. Given the significant safety concerns related to potential aristolochic acid alkaloid contamination, any recommendation for dosage is severely limited, and caution is strongly advised.

FAQs

Is *Houttuynia cordata* safe to use?

The safety of *Houttuynia cordata* is a major concern due to the potential presence of nephrotoxic and carcinogenic aristolochic acid alkaloids. High-quality human safety data is lacking, and its use is not recommended without strict verification of the absence of these toxic compounds.

What are the proven benefits of *Houttuynia cordata*?

Despite traditional use and promising preclinical studies, there are currently no high-quality human clinical trials that definitively prove the efficacy of *Houttuynia cordata* for any health condition. More research is needed to establish its benefits.

Can *Houttuynia cordata* interact with medications?

There is no available data on drug interactions with *Houttuynia cordata*. Given the lack of safety data, it is advisable to consult a healthcare professional before combining it with any medications.

Who should avoid using *Houttuynia cordata*?

Individuals with kidney disease, pregnant or lactating women, and children should avoid *Houttuynia cordata* due to significant safety concerns, particularly the risk of aristolochic acid toxicity, and the lack of safety data for these groups.

How should I take *Houttuynia cordata*?

There are no established dosing guidelines or recommendations for the administration of *Houttuynia cordata*. Traditional preparations vary, and without clear safety and efficacy data, specific usage instructions cannot be provided.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC7748356/ – This is a systematic review protocol outlining the methodology to assess the efficacy and safety of *Houttuynia cordata* nasal irrigation for rhinosinusitis. It details the search strategy, inclusion criteria for studies, and planned data analysis, including a meta-analysis if sufficient randomized controlled trials are found. However, it does not present any results or conclusions, as it is a protocol for future research.
  • https://pubmed.ncbi.nlm.nih.gov/33371097/ – This entry refers to the same systematic review protocol as the previous source, published in Medicine (Baltimore). It describes the intention to evaluate the effectiveness and safety of *Houttuynia cordata* nasal irrigation for rhinosinusitis through a systematic review and meta-analysis of randomized controlled trials. No actual study results or findings are provided, as it is a pre-registered protocol.
  • https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1306375/full – This review article discusses the potential of *Houttuynia cordata* in inflammatory bowel disease (IBD), focusing on its preclinical mechanisms such as modulating the intestinal microenvironment through volatile oils, polysaccharides, and flavonoids. It highlights the promising anti-inflammatory and immunomodulatory effects observed in animal and in vitro studies. Crucially, the article also raises significant safety concerns regarding the presence of nephrotoxic and carcinogenic aristolochic acid alkaloids in the plant.
  • https://www.nature.com/articles/s41598-020-80183-7 – This study investigates the bioaccumulation of mercury in *Houttuynia cordata* grown in contaminated soils. It demonstrates that the plant can absorb and accumulate mercury, particularly in its roots, indicating a potential risk of mercury exposure if the plant is consumed from contaminated environments. This research is relevant for assessing the safety and sourcing of *Houttuynia cordata* for human consumption, highlighting an environmental contaminant risk.

Recommended Articles

Top Fertility Supplements for Women in 2025

Top Fertility Supplements for Women in 2025

By 2025, new FDA-approved fertility supplements, emphasizing organic ingredients, have shown significant effectiveness in aiding conception for women in their 30s.

Barcode-Scanner Apps & Supplements: A Reality Check

Barcode-Scanner Apps & Supplements: A Reality Check

Barcode-scanner supplement apps vary in accuracy, especially with proprietary blends, but advancements are improving their reliability.

Legal Pre-Workout Supplements for Athletes

Legal Pre-Workout Supplements for Athletes

Legal pre-workout supplements like those with caffeine, beta-alanine, and creatine can safely enhance athletic performance without failing doping tests.

Top Testosterone Boosters for Cyclists: A Buyer's Guide

Top Testosterone Boosters for Cyclists: A Buyer's Guide

For cyclists, choosing testosterone boosters involves finding scientifically-backed, third-party tested products, with top picks including brands like TestoGen and Prime Male.